Shishko Ilona, Almeida Kenneth, Silvia Richard J, Tataronis Gary R
MCPHS University, School of Pharmacy - Boston, 179 Longwood Avenue, Boston, MA 02115, USA.
Pharmacogenomics. 2015;16(9):949-58. doi: 10.2217/pgs.15.22. Epub 2015 Jun 23.
Pharmacogenomics could play a role in improving patient care, reducing adverse drug reactions and overall healthcare costs. However, whether it is utilized may be determined by how it is perceived by healthcare professionals, including pharmacists.
A cross-sectional web-based survey evaluated psychiatric pharmacists' use, knowledge and perception of the effectiveness of such testing.
Among participants, 80% worked at sites not offering pharmacogenomic testing, mostly due to a lack of funding. About 36% of pharmacists considered themselves more knowledgeable and 47% considered themselves less knowledgeable about pharmacogenomic testing; however, most agreed on the potential usefulness of testing.
Among psychiatric pharmacists, the use of pharmacogenomics appears underappreciated due to factors such as lack of availability and understanding of testing. Original submitted 26 November 2014; Revision submitted 13 February 2015.
药物基因组学在改善患者护理、减少药物不良反应以及降低总体医疗成本方面可能发挥作用。然而,其是否被采用可能取决于包括药剂师在内的医疗专业人员对它的认知。
一项基于网络的横断面调查评估了精神科药剂师对此类检测的使用情况、知识掌握程度以及对其有效性的认知。
在参与者中,80%在未提供药物基因组学检测的机构工作,主要原因是缺乏资金。约36%的药剂师认为自己对药物基因组学检测了解较多,47%认为自己了解较少;然而,大多数人认同检测的潜在有用性。
在精神科药剂师中,由于检测难以获得以及对检测缺乏了解等因素,药物基因组学的应用似乎未得到充分重视。原始稿件于2014年11月26日提交;修订稿件于2015年2月13日提交。